
Saftrax 250mg Injection
Marketer
Pluzine Healthcare
Salt Composition
Ceftriaxone (250mg)
Overview Saftrax 250mg Injection
Cefixime 250mg injection, a cephalosporin antibiotic, combats bacterial infections throughout the body. Its applications encompass infections of the central nervous system (meningitis), respiratory system (pneumonia), ears, urinary tract, skin, bones, joints, bloodstream, and heart. Prophylactically, it may prevent surgical site infections. Administered intravenously or intramuscularly by a healthcare professional, dosage is determined individually. Consistent, evenly-spaced doses, as directed, are crucial; premature discontinuation risks relapse. Common side effects, typically mild, include diarrhea, skin rash, altered liver function tests, and variations in blood cell counts (e.g., eosinophilia, leukopenia, thrombocytopenia). Injection site reactions (erythema, pain) may occur temporarily. Report any persistent or bothersome side effects. Prior to treatment, disclose any antibiotic allergies, kidney or liver issues, and all concurrent medications to ensure safe and effective use.
Primary Ingredients of Saftrax 250mg Injection
There is no text provided to rephrase.
Uses of Saftrax 250mg Injection
Managing bacterial illnesses
Major Benefits of Saftrax 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Saftrax 250mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Saftrax 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Saftrax 250mg Injection works:
The antibiotic injection, Saftrax 250mg, eradicates bacteria by disrupting their cell wall synthesis, a crucial process for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Saftrax 250mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Saftrax, 250mg, is considered safe for use during gestation. The majority of research indicates minimal or negligible risk to the fetus.
Breast feedingCAUTION
Administering Saftrax 250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Saftrax 250mg Injection can induce drowsiness, blurred vision, and dizziness. Driving is inadvisable if these effects are experienced.
KidneySAFE IF PRESCRIBED
Cefixime 250mg injection poses no safety concerns for patients with kidney impairment; dosage modification is unnecessary. Nevertheless, disclosure of any pre-existing kidney condition to your physician is advised.
LiverCAUTION
The use of Saftrax 250mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the Saftrax 250mg Injection dosage is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Saftrax 250mg Injection :
Omit a Saftrax 250mg Injection dose? Seek your physician's advice.
Facts to Know About Saftrax 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
